Annual Scientific Meeting 2023


The Melanoma and Skin Cancer (MASC) Trials 2023 Annual Scientific Meeting will bring together leading figures in melanoma and skin cancer clinical trials to share the latest findings and foster further innovative research.

The program will feature international keynote speakers, presentations on MASC Trials clinical research and consumer sessions.

The MASC Trials ASM will be a satellite meeting of the Australasian Melanoma Conference (AMC), to be held 24-25 March 2023, Brisbane Convention and Exhibition Centre.

Event Details

Time: 2pm – 5pm (AEST)
Date: Thursday, 23 March 2023
Venue: Boulevard B1, Brisbane Convention and Exhibition Centre (BCEC)

The MASC Trials ASM is a face-to-face event only.

Registration fees
Full registration for medical practitioners: $80
Concession for non-medical practitioners: $40

Seating is limited and is restricted to the first 120 people who register for the MASC Trials ASM.


The program will feature international keynote speakers and a stellar line-up of leaders in their field who will discuss the latest clinical research in melanoma and skin cancer. Updates on MASC Trials’ research portfolio and opportunities for new research collaborations will form part of the meeting. Consumer presentations will also provide a unique perspective on our patient engagement.

International keynote speakers

Prof Harald Kittler
Department of Dermatology, Medical University of Vienna, Austria

Talk: Clinical trials on AI-assisted diagnosis of melanoma

Sapna Patel, M.D. 
Dr Sapna Patel is a medical oncologist and Associate Professor, Director of the Uveal Melanoma Program, and Melanoma Fellowship Program Director at the University of Texas MD Anderson Cancer Center in Houston, Texas. She is also Chair of the SWOG Cancer Research Network Melanoma Committee and has led several investigator-initiated, multi-institutional, and international clinical trials. Her grant work focuses on translational research characterising tumour and tissue samples from patients receiving treatment.

Talk: SWOG melanoma portfolio: Past, present, and future states 

More speakers will be announced soon

Who should attend?

The meeting is relevant to those who represent the many disciplines critical to our work including:

Radiation specialists

Allied health professionals
Health economists

Research scientists
Research students
Clinical trial coordinators
Data managers
Consumers / patient advocates and their families

Sponsorship opportunities available

MASC Trials offers a range of benefits to sponsors of its Annual Scientific Meeting. If your company is interested in sponsoring this event, please email for further details. Customised sponsorship packages are available.

MASC Trials ASM 2023 organising committee

  • Prof Mark Shackleton, Board Chair of Melanoma and Skin Cancer Trials, Director of Oncology at Alfred Health, Professor of Oncology at Monash University, and Director of Cancer Trials Australia
  • Gabrielle Byars, CEO, Melanoma and Skin Cancer Trials
  • Merrin Morrison, Marketing and Communications Manager, Melanoma and Skin Cancer Trials
  • Ayeshini Sella Hewage, Clinical Trials Assistant
  • Elizabeth Sadowey, Executive Assistant / Senior Officer Administrator, Melanoma and Skin Cancer Trials



Phone: +61 3 9903 9022